Leighann Desanto
About Leighann Desanto
Leighann Desanto is an Expedited Safety Reporting Scientist at Bristol-Myers Squibb with extensive experience in the pharmaceutical industry, including roles at Pfizer, Celgene, Roche, Medarex, Novartis, and Abbot Laboratories.
Title
Leighann Desanto is currently an Expedited Safety Reporting Scientist at Bristol-Myers Squibb. She has been with the company since September 2017, working in New Jersey, United States.
Career at Bristol-Myers Squibb
Since September 2017, Leighann Desanto has been employed by Bristol-Myers Squibb as an Expedited Safety Reporting Scientist. Her role primarily involves ensuring the swift and accurate reporting of safety data pertaining to pharmaceutical products.
Previous Experience in Pharmaceutical Industry
Leighann Desanto has extensive experience in the pharmaceutical industry, spanning several key companies and roles. She worked as a Quality Analyst at Pfizer from 2013 to 2015 in New York, and as a Drug Safety Scientist at Celgene from 2011 to 2012 in Summit, New Jersey. Additionally, she held positions at Roche as a Clinical Safety Scientist from 2010 to 2011 in Switzerland, at Medarex as a Clinical Data Reviewer from 2009 to 2010 in Princeton, New Jersey, and at Novartis as a Drug Safety Scientist from 2006 to 2008 in Basel, Switzerland. Earlier in her career, she worked as a Clinical Safety Associate at Abbot Laboratories in Waxhaw, North Carolina, in 2005.
Career Beginnings at Dendrite and Medical Background
Leighann Desanto's career began at Dendrite as a Medical Information Specialist in 2005, a role she held for six months. She also worked at Porzio Bromberg & Newman P.C. as a Nurse Investigator from 2003 to 2005 in Morristown, New Jersey. Her clinical background is in cardiology and legal pharmaceutical product liability, providing her a strong foundation for her subsequent roles in the pharmaceutical industry.
Experience at Roche and Novartis
Leighann Desanto served as a Clinical Safety Scientist at Roche from 2010 to 2011 in Switzerland, where she was involved in ensuring the clinical safety of pharmaceutical products. Prior to that, she worked at Novartis as a Drug Safety Scientist from 2006 to 2008 in Basel, Switzerland, where she handled drug safety assessments and reporting obligations.